Skip to main content

November 10, 2015

Hursting receives NCI Outstanding Investigator Award

UNC Lineberger researcher Stephen Hursting, PhD, MPH is a recipient of the NCI Outstanding Investigator Award for 2015. Hursting was in the first class of recipients of the seven-year grant award, which supports investigators with outstanding records of productivity in cancer research by providing extended funding stability and encouraging investigators to continue or embark on projects of unusual potential in cancer research.

ouise M. Henderson, MSPH, PhD, is a UNC Lineberger member and assistant professor in the UNC School of Medicine Department of Radiology.

October 28, 2015

Menopausal status may be more important than age in breast cancer screening frequency, study finds

A study published in JAMA Oncology found that pre-menopausal women who were diagnosed with breast cancer following a biennial screening mammogram were likely to have more advanced tumors than woman screened annually. UNC Lineberger researcher Louise Henderson was a co-author on the study, which was co-led by researchers at the University of California-Davis School of Medicine and the Dana-Farber Cancer Institute.

Drs. Channing Der and Adrienne Cox

October 28, 2015

Cox, Der lead team to $2M+ NCI U01 grant

A research team led by Drs. Adrienne D. Cox and Channing J. Der (members of the UNC Lineberger Program in Molecular Therapeutics) is one of the first recipients of an NCI U01 grant on New Approaches to Synthetic Lethality for Mutant KRas-Dependent Cancers. Their team, which also includes Drs. Ben Major at UNC, Kris Wood at Duke and Krister Wennerberg at FIMM, will pursue novel genetic screens to search for the long-elusive effective anti-KRAS cancer treatment.

Charles M. Perou, PhD, is a UNC Lineberger member and the May Goldman Shaw Distinguished Professor of Molecular Oncology.

October 26, 2015

Finding could help predict whether breast cancer will spread to the brain

A study co-led by scientists at The Institute of Cancer Research, London, and the University of Wisconsin Carbone Cancer Center, in collaboration with UNC Lineberger Comprehensive Cancer Center researcher Charles M. Perou found that women whose breast cancer had begun to spread and who tested positive in the αB-crystallin test were three times more likely to have disease that spread to the brain than those who tested negative.